Read the full stored bill text
House
File
14
-
Introduced
HOUSE
FILE
14
BY
A.
MEYER
A
BILL
FOR
An
Act
relating
to
the
controlled
substance
crystalline
1
polymorph
psilocybin.
2
BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
3
TLSB
1725YH
(3)
91
as/js
H.F.
14
Section
1.
Section
124.201,
Code
2025,
is
amended
by
adding
1
the
following
new
subsection:
2
NEW
SUBSECTION
.
5.
a.
Notwithstanding
section
124.204,
3
subsection
4,
a
drug
that
contains
the
pharmaceutical
4
composition
of
crystalline
polymorph
psilocybin,
also
known
as
5
COMP
360,
or
any
other
trade
name
approved
by
the
United
States
6
food
and
drug
administration,
shall
be
immediately
removed
7
from
schedule
I
under
section
124.204,
subsection
4,
paragraph
8
“s”
,
upon
its
approval
by
the
United
States
food
and
drug
9
administration
and
rescheduled
based
upon
the
recommendations
10
of
the
United
States
food
and
drug
administration
and
its
11
listing
in
the
federal
Controlled
Substances
Act,
21
U.S.C.
12
§812,
and
21
C.F.R.
§1308.14.
13
b.
Immediately
upon
the
rescheduling
of
the
drug
under
14
paragraph
“a”
,
it
shall
be
lawful
to
prescribe,
distribute,
and
15
market
the
pharmaceutical
composition
of
crystalline
polymorph
16
psilocybin,
also
known
as
COMP
360,
or
any
other
trade
name
17
approved
by
the
United
States
food
and
drug
administration.
18
EXPLANATION
19
The
inclusion
of
this
explanation
does
not
constitute
agreement
with
20
the
explanation’s
substance
by
the
members
of
the
general
assembly.
21
This
bill
relates
to
the
controlled
substance
crystalline
22
polymorph
psilocybin.
23
Current
law
categorizes
the
controlled
substance
psilocybin
24
as
a
schedule
I,
hallucinogenic
substance
(Code
section
25
124.201(4)(s)).
26
The
bill
provides
that
notwithstanding
Code
section
27
124.204(4),
a
drug
that
contains
the
pharmaceutical
composition
28
of
crystalline
polymorph
psilocybin
shall
be
immediately
29
removed
from
schedule
I
upon
its
approval
by
the
United
30
States
food
and
drug
administration
and
rescheduled
based
31
upon
the
recommendations
of
the
United
States
food
and
drug
32
administration
and
its
listing
in
the
federal
Controlled
33
Substances
Act.
34
The
bill
provides
that
upon
the
rescheduling
of
psilocybin,
35
-1-
LSB
1725YH
(3)
91
as/js
1/
2
H.F.
14
it
shall
be
lawful
to
prescribe,
distribute,
and
market
the
1
pharmaceutical
composition
of
crystalline
polymorph
psilocybin.
2
Current
penalties
for
the
possession
of
psilocybin
range
3
from
a
serious
misdemeanor
to
a
class
“B”
felony.
4
-2-
LSB
1725YH
(3)
91
as/js
2/
2